Immunotherapy and Immune Responses
Immunotherapy and Immune Responses is a research topic within Immunology. Science Explorer counts 90k research works in it since 1950. 22.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the immunobiology of dendritic cells, their role in antigen presentation, modulation of immunity, and their potential applications in cancer immunotherapy and vaccine development. The research covers topics such as dendritic cell subsets, tumor antigen presentation, immune tolerance, and the use of adjuvants to enhance immune responses.
- Dendritic Cells
- Immunity
- Cancer Immunotherapy
- Antigen Presentation
- Tumor Antigen
- Vaccine Adjuvants
- T Cell Immunity
- Cross-Presentation
- Innate Immunity
- Therapeutic Vaccines
- Research works
- 90k fractional, since 1950
- In the world top 10%
- 20k per year above
- Top-10% rate
- 22.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +18% the tick is no change
Which countries lead Immunotherapy and Immune Responses research?
By volume, the United States and China publish the most (3.6k and 3.2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 3.6k works
- 2 China 3.2k works
- 3 Germany 600 works
- 4 Japan 513 works
- 5 India 423 works
- 6 United Kingdom 419 works
- 7 France 408 works
- 8 Italy 330 works
- 9 South Korea 301 works
- 10 Spain 257 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Immunotherapy and Immune Responses research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Immunotherapy and Immune Responses research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Sichuan University.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 93 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 77 works
- 3 Sichuan UniversityChina 63 works
- 4 Sun Yat-sen UniversityChina 62 works
- 5 Harvard UniversityUnited States 58 works
- 6 Shanghai Jiao Tong UniversityChina 54 works
- 7 University of North Carolina at Chapel HillUnited States 52 works
- 8 University of PennsylvaniaUnited States 50 works
- 9 InsermFrance 49 works
- 10 Moffitt Cancer CenterUnited States 46 works
Who are the leading researchers in Immunotherapy and Immune Responses?
The most-cited researchers publishing on Immunotherapy and Immune Responses include Kenneth J. Livak, Eric S. Lander and Ahmedin Jemal.
- 1 Kenneth J. Livak United States 20k citations
- 2 Eric S. Lander United States 8.5k citations
- 3 Ahmedin Jemal United States 4.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Immunotherapy and Immune Responses research done?
The largest centres of Immunotherapy and Immune Responses research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Kirov.
Largest cities, 2022–2025
Where it is the local speciality
- KirovRU · 27.9 works31×
Location quotient: how much more of its research is in Immunotherapy and Immune Responses than the world average.
Where is the best place to study Immunotherapy and Immune Responses?
Among universities, judged by research, Oncode Institute, Chinese Academy of Medical Sciences & Peking Union Medical College and Shenyang Pharmaceutical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Oncode InstituteNetherlands | 66.5 | 46.5% | 41.8× | 15 | +40.6% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 58.5 | 35.3% | 6.3× | 77 | +26.9% |
| 3 | Shenyang Pharmaceutical UniversityChina | 58.4 | 33.9% | 12.3× | 20 | +79.5% |
| 4 | China Pharmaceutical UniversityChina | 56.8 | 36.5% | 9.0× | 24 | +42.3% |
| 5 | Sichuan UniversityChina | 55.7 | 47.8% | 3.0× | 64 | +49.8% |
| 6 | Shanghai Medical College of Fudan UniversityChina | 55.3 | 42.1% | 10.0× | 10 | +24.7% |
| 7 | China Medical UniversityChina | 51.4 | 46.9% | 5.8× | 24 | +2.3% |
| 8 | Soochow UniversityChina | 51.2 | 44.4% | 4.3× | 43 | -4.5% |
| 9 | Sun Yat-sen UniversityChina | 50.6 | 41.2% | 3.1× | 62 | +10.2% |
| 10 | Tabriz University of Medical SciencesIran | 50.5 | 31.8% | 5.0× | 14 | +222.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Immunotherapy and Immune Responses research growing?
Output in 2018–2022 was 18% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Immunotherapy and Immune Responses.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.